Search Results
Aug 31, 2026, 09:00 ET Norm Law Adds Established Blue Sky Filings Team
brings almost 30 years of experience advising investment banking and fund management clients on securities regulatory matters. He has coordinated Form D and state notice filings for hedge funds, commodity pools, and private equity funds and led large-scale, 50-state remediation projects involving registration
More news about: Norm Law
Aug 31, 2026, 09:00 ET GT Independence Strengthens Leadership Team: Appoints Chris Karkenny as CEO
60,000 people self-directing their care in more than 21 states. He joins a leadership team with deep expertise in self-direction, including President D. Pearl Barnett and John Carmichael, GT Independence's founder and former CEO, who will continue to support the company as a member of the board.
More news about: GT Independence
Aug 31, 2026, 08:40 ET COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS
medicine and advanced high-performance computing. In the healthcare sector, CollPlant is ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair, and medical aesthetics. The Company's products are based on its recombinant human collagen produced
More news about: CollPlant
Aug 31, 2026, 08:33 ET Disney Springs® Resort Area Hotels Extend Fantastic Fall Rate Starting at $125
country, Australia, at "Jumping Junction."Clap your paws and click your claws at "Zootopia: Better Zoogether!", an all-new 4-D show at the Tree of Life Theater in Disney's Animal Kingdom Theme Park.About Disney Springs Resort Area HotelsThe Disney Springs
More news about: Disney Springs Resort Area Hotels
Aug 31, 2026, 08:30 ET Genpact Names Priya Vijayarajendran Chief Product and Platform Officer
world's largest enterprises. Earlier, as ASAPP's President of Technology and Chief Technology Officer, she built its generative AI platforms and led an R&D agenda that produced more than 70 AI patents.Prior to ASAPP, she led Microsoft's global Azure Data and AI business, and she served as IBM's
More news about: Genpact
Aug 31, 2026, 08:30 ET LG Energy Solution Secures Multi-Year Supply of U.S.-Produced Lithium Carbonate from Smackover Lithium
IT, and energy storage systems. With more than 30 years of experience in revolutionary battery technology and extensive research and development (R&D), the company is the top battery-related patent holder in the world with over 100,000 patents. Its robust global network, which spans North America,
More news about: LG Energy Solution
Aug 31, 2026, 08:22 ET CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum
and other key disease areas, today announced its 2026 interim results and recent business highlights. Dr. Jason Yang, CEO, President of R&D, and Executive Director at CStone, commented, "In the first half of 2026, CStone entered a pivotal stage of transition from innovation-driven accumulation
More news about: CStone Pharmaceuticals
Aug 31, 2026, 08:21 ET CMMC Phase II Is Paused, but Defense Contractors Face DFARS and FAR Cybersecurity Requirements
www.magna5.com.Sources:Abrahams, J. C., Horan, J. G., Pashkoff, D. B., Francois, M. Y., & Young, A. F. (2026, July). DoD suspends CMMC Phase II third-party audit requirements. Faegre Drinker Biddle & Reath LLP.
More news about: Magna5
Aug 31, 2026, 08:15 ET CHINT presentó soluciones de energía avanzadas en CIGRE 2026
desde interfaces de transmisión de 400 kV hasta distribución de media tensión", afirmó el doctor Naihu Li, vicepresidente de CHINT T&D y director del Instituto de I+D del Grupo CHINT."Estas soluciones están diseñadas con arquitecturas modulares de rápida implementación, lo que
More news about: CHINT
Aug 31, 2026, 08:00 ET Innoviz Technologies Appoints Yoav Har-Even as Chairperson of the Board of Directors
chairperson of the board of directors of Sindiana Technologies (S.T.) Ltd. and as a member of the advisory boards of Ondas Holdings Inc. and Massivit 3D Printing Technologies Ltd. Mr. Har-Even holds a B.A. in Economics and Political Science and an Executive MBA (cum laude), both from Tel Aviv University."On
More news about: Innoviz Technologies
Aug 31, 2026, 07:55 ET Crooked Pop Names Lee Schill Chief Commercial Officer
execution."It's our ambition to establish zero-sugar hard soda as a durable category in the growing Ready-to-Drink market. We've spent years in R&D developing a wholly new alcohol base, fermented from ancient grains, that delivers the flavor and fun modern drinkers expect—and the ingredient transparency
More news about: Crooked
Aug 31, 2026, 07:45 ET Corvex Announces Significant Data Center Expansion; Increasing Current Capacity 5x with Contracted Path to 13x
development risk relative to greenfield construction.The expansion will be funded with proceeds from a private placement of common stock and Series D Preferred Stock ("PIPE") led by Goldman Sachs & Co. LLC, Morgan Stanley and Oppenheimer & Co. acting as Joint Lead Placement Agents. The transaction
More news about: Corvex
Aug 31, 2026, 07:00 ET Summit Midstream Corporation Announces Final Investment Decision on Double E Pipeline Mainline Compression Expansion
approvals.With the new 200 MMcf/d agreement, Double E has secured approximately 550 MMcf/d of binding long-term take-or-pay commitments through the compression expansion open season. Total contracted firm capacity on the pipeline is now approximately 2.2 Bcf/d, held by a diversified group of primarily
More news about: Summit Midstream Corporation
Aug 31, 2026, 07:00 ET RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
GI intolerance, positive results from a U.S. Phase 3 study for acute gastroenteritis and gastritis, positive results from a U.S. Phase 2 study for IBS-D and potential UK submission for chemotherapy and radiotherapy induced nausea and vomiting. RHB-102 is partnered with Hyloris Pharmaceuticals (EBR: HYL)
More news about: RedHill Biopharma Ltd.
Aug 31, 2026, 07:00 ET RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
GI intolerance, positive results from a U.S. Phase 3 study for acute gastroenteritis and gastritis, positive results from a U.S. Phase 2 study for IBS-D and potential UK submission for chemotherapy and radiotherapy induced nausea and vomiting. RHB-102 is partnered with Hyloris Pharmaceuticals (EBR: HYL)
More news about: RedHill Biopharma Ltd.
Aug 31, 2026, 07:00 ET Defense Metals Resource Upgrade Drilling Intersects 2.86% TREO over 65 Metres; Including 6.15% TREO over 20 Metres at the Wicheeda Rare Earth Project
Aug. 31, 2026 /PRNewswire/ -- Defense Metals Corp. ("Defense Metals" or the "Company"); (TSXV: DEFN) (OTCQB: DFMTF) (FSE:35D) is pleased to announce assay results for an initial eleven core drill holes, totalling 1,633 metres (m), completed during
More news about: Defense Metals Corp.
Aug 31, 2026, 06:33 ET Continuous Composites Awarded U.S. Navy Phase II Contract to Advance CF3D Technology for Embedded Electrical Systems in UAV Structures
CompositesContinuous Composites is advancing the future of composite manufacturing with CF3D®—its patented Continuous Fiber 3D Printing technology. By integrating fiber steering, advanced materials, and automated manufacturing, CF3D enables high-performance structures with exceptional design agility for aerospace,
More news about: Continuous Composites
Aug 31, 2026, 06:17 ET HUAWEI WATCH D3 debiutuje na Kongresie ESC 2026. Nowa era monitorowania ciśnienia tętniczego za pomocą pomiarów na nadgarstku
HUAWEI WATCH D. Urządzenie po raz pierwszy umożliwiło wykonywanie na nadgarstku pomiarów ciśnienia tętniczego o jakości medycznej, uzyskując certyfikaty wyrobu medycznego w wielu krajach i regionach, w tym w Chinach i Unii Europejskiej. W 2024 roku oficjalnie zadebiutował HUAWEI WATCH D2, wyposażony w
More news about: Huawei
Aug 31, 2026, 06:00 ET IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer
and median OS as the primary endpoint for potential full approvalDose evaluation ongoing of 2.4mg/kg and 3.5 mg/kg IV Q3W to determine the RP3DTarget enrollment for the Phase 3 study will be ~400 ES-SCLC patients, randomized 1:1 treatment vs. investigator's choiceClinical data
More news about: IDEAYA Biosciences, Inc.
Aug 31, 2026, 05:37 ET Fosun International Holds 2026 Interim Results Presentation: Unlocking Core Pathways, Accelerating Growth in Industries where we Excel
of sustained commitment to innovative R&D, Chinese biopharmaceutical companies now face a critical global challenge they must overcome: global operational capabilities, particularly global commercialization capabilities. To that end, beyond advancing R&D innovation, Fosun is taking a key strategic
More news about: Fosun
Aug 31, 2026, 05:16 ET TCL CSOT Showcases New Innovations and Insights into the Future of Displays at DIC EXPO 2026
In response to this trend, Bin Zhao, VP of TCL CSOT, GM of R&D Platform of TCL CSOT, stated at DIC EXPO 2026: "Through APEX, our advanced display technology brand, we are advancing innovation across four key
More news about: TCL CSOT
Aug 31, 2026, 04:55 ET YFORE presenta el sistema de detección en cabina ODMS para mejorar la seguridad en la cabina
penetra mantas, ropa y respaldos altos para capturar la microrespiración en las filas traseras y el espacio para los pies, logrando una cobertura espacial 3D completa.Detección integral en consonancia con los estándares de seguridadLa arquitectura ODMS abarca siete funciones principales:
More news about: YFORE
Aug 31, 2026, 03:14 ET DiDi Autonomous Driving Begins Fully Driverless Service Trials with Next-Generation Robotaxi R2
for more than 2,200 consecutive days. Guided by responsible technology innovation and user needs, the company continues to invest in core technology R&D and bring its autonomous-driving technologies and operational experience to global markets.
More news about: DiDi
Aug 31, 2026, 03:14 ET DiDi Autonomous Driving Begins Fully Driverless Service Trials with Next-Generation Robotaxi R2
for more than 2,200 consecutive days. Guided by responsible technology innovation and user needs, the company continues to invest in core technology R&D and bring its autonomous-driving technologies and operational experience to global markets.
More news about: DiDi
Aug 31, 2026, 03:01 ET Share buybacks in Ericsson during the period August 24 - August 28, 2026
https://mb.cision.com/Public/15448/4389512/8e96763d7daa75ff.xlsxDaily Ericsson Share
More news about: Ericsson